Development of cancer vaccine by tumor rejection antigens

International Reviews of Immunology

Volumn 14, Issue 2-3, 1997, Pages 153-171

  Itoh, Kyogo ^a   Hayashi, Akihiro ^a   Toh, Yuji ^a   Imai, Yasuhisa ^a   Yamada, Akira ^a   Nishida, Takashi ^a   Shichijo, Shigeki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer vaccine; Cytotoxic T lymphocytes; HLA class 1; MAGE gene; Specific immunotherapy

Indexed keywords

EID: 0030942296     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189709116850     Document Type: Review

References (29)

1. Itoh, K., Platsoucas, C.D., and Balch, C.M, Autologous tumor specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. J Exp. Med. 168, 1419-1441, 1988.
2. Anichini, A., Maccalli, C., Mortarini, R., Salvi, S., Mazzocchi, A., Squaricina, P., Herlyn, M., and Parmiani, G. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J. Exp. Med. 177, 989-998, 1993.
3. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on an human melanoma. Science 254, 1643-1647, 1991.
4. Kawakami, Y., Ehyahu, S., Delgado, C.H., Robbins, P.F., Rivoltini, L., Topalian, S.L., Miki, T., and Rosenberg, S.A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cell infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91, 3515-3519, 1994.
5. Coulie, P.G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytologic T lymphocytes on HLA-A2 Traversari, C., Plaen, E.DE., Lurquin, C., Szikora, J.-P., Renauld, J.-C., melanomas. J. Exp. Med. 180, 35-42, 1994.
6. Kawakami, Y., Eliyahu, S., Delgado, C.H., Robbins, P.F., Sakaguchi, K., Appella, E., Yannelli, J.R., Adema, G.J., Miki, T., and Rosenberg, S.A. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91, 6458-6462, 1994.
7. Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178, 489-495, 1993
8. De Plaen, E., Arden, K., Traversari, C., Gaforio, J.J., Szikora, J.-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethe, B., Lurquin, C., Brassuer, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40, 360-369, 1994.
9. Traversari, C., van der Bruggen, P., Luescher, I.F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176, 1453-1457, 1992.
10. van der Bruggen, P., Szikora, J.-P., Boel, P., Wildmann, C., Somville, M., Sensi, M., and Boon, T. Autologous cytotoxic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLACw* 1601. Eur. J. Immunol. 24, 2134-2140, 1994.
11. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P.G., Boel, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytotoxic T lymohocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24, 3038-3043, 1994.
12. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J.J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921-930, 1994.
13. De Smet, C., Lurquin, C., van der Bruggen, P., De Plaen, E., Brasseur, F., and Boon, T. Sequence and expression pattern of the human MAGE-2 gene. Immunogenetics 39, 121-129, 1994.
14. Weynants, P., Lethe, B., Brasseur, F., Marchand, M., and Boon, T. Expression of MAGE genes by non-small-cell lung carcinomas. Int. J. Cancer 56, 826-829, 1994.
15. Zakut, R., Topalian, S.L., Kawakami, Y., Mancini, M., Eliyahu, S., and Rosenberg, S.A. Differential expression of MAGE-1, -2 and -3 messenger RNA in transformed and normal human cell lines. Cancer Res. 53, 5-8, 1993.
16. Brasseur, F., Marchand, M., Vanwijck, R., Herin, M., Lethe, B., Chomez, P., and Boon, T. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int. J. Cancer 52, 839-841, 1992.
17. Rimoldi, D., Romero, P., and Carrel, S. The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int. J. Cancer 54, 527-528, 1993.
18. Shichijo, S., Hayashi, A., Takamori, S., Tsunosue, R., Hoshino, T., Sakata, M., Kuramoto, T., Oizumi, K., and Itoh, K. Detection of MAGE-4 protein on lung cancers. Int. J. Cancer 64, 158-165, 1995.
19. Toh, Y., Yamana, H., Shichijo, S., Fujita, H., Tou, U., Sakaguchi, M., Kakegawa, T., and Itoh, K. Expression of MAGE-1 gene by esophageal carcinomas. Jap. J. Cancer Res. 1995, in press.
20. Shichijo, S., Tsunosue, R., Imai, Y., Masuoka, K., Natori, H., Tamai, M., Miyajima, J., Sakata, M., Sagawa, K., and Itoh, K. Preferential expression of MAGE gene family on human lymphocytic leukemias. Cancer Immunol. Immunother. 1995, in press.
21. Eura, M., Ogi, K., Chikamatsu, K., Dae, L.K., Nakano, K., Masuyama, K., Itoh, K., and Ishikawa, T. Expression of MAGE gene family by human head and neck squamous cell carcinomas. Int. J. Cancer 1995, in press.
22. Yamada, A., Kataoka, A., Shichijo, S., Kamura, T., Imai, Y., Nishida, T., and Itoh, K. Expression of MAGE genes in ovarian tumors. Int. J. Cancer 1995, in press.
23. Imai, Y., Shichijo, S., Yamada, A., Katayama, T., Yano, H., and Itoh, K. Sequence analysis of the MAGE gene family encoding human tumor-rejection antigens. Gene 1995, in press.
24. Takahashi, K., Shichijo, S., Noguchi, M., Hirohata, M., and Itoh, K. Identification of MAGE-1 and -4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res. vol. 55, no. 16, 1995, in press.
25. Chen, Y-T., Stockert, E., Chen, Y., Garin-Chesa, P., Rettig, W.J., van der Bruggen, P., Boon, T., and Old, L.J. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc. Natl. Acad. Sci. USA 91, 1004-1008, 1994.
26. Schultz-Thater, E., Juretic, A., Dellabona, P., Luscher, U., Siegrist, W., Harder, F., SHeberer, M., Zuber, M., and Spagnoli, G.C. MAGE-1 gene product is a Scytoplasmic protein. Int. J. Cancer 59, 435-439, 1994.
27. Russell, L.D., Ettlin, R.A., Shinha Hikim, A.P., and Clegg, E.D. Mammalian Spermatogenesis. In: Russell, L.D., Ettlin, R.A., Shinha Hikim, A.P., and Clegg, E.D. (eds.), Histological and Histopathological Evaluation of the Testis, pp. 1-40. Clearwater, FI, 1990.
28. Becker, J.C., Gillitzer, R., and Brocker, E -B. A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int. J. Cancer 58, 346-348, 1994.
29. Shichijo, S., Tsunosue, R., Kubo, K., Kuramoto, T., Tanaka, Y., Hayashi A., and Itoh, K. Establishment of an enzyme-linked immunosorbent assay (ELISA) for measuring cellular MAGE-4 protein on human cancers. J. Immunol. Meth. 1995, in press.